Publications:

A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.

Genome Research

Chen, Siwei S; Liu, Yuan Y; Zhang, Yingying Y; Wierbowski, Shayne D SD; Lipkin, Steven M SM; Wei, Xiaomu X; Yu, Haiyuan H

Publication Date: 2022-01

Variant appearance in text: EZH2: Q94R

PubMed Link: 34963661

Variant Present in the following documents:

• supp_gr.275437.121_Supplementary_Table_1.xlsx, sheet 3

View BVdb publication page

Germline POT1 variants can predispose to myeloid and lymphoid neoplasms.

Leukemia

Lim, Tristan L TL; Lieberman, David B DB; Davis, Adam R AR; Loren, Alison W AW; Hausler, Ryan R; Bigdeli, Ashkan A; Li, Yimei Y; Powers, Jacquelyn J; Raper, Anna A; Regeneron Genetics Center, ; Carty, Shannon A SA; Nathanson, Katherine L KL; Bagg, Adam A; Hexner, Elizabeth O EO; Maxwell, Kara N KN; Morrissette, Jennifer J D JJD; Babushok, Daria V DV

Publication Date: 2022-01

Variant appearance in text: EZH2: Q94R

PubMed Link: 34193977

Variant Present in the following documents:

• NIHMS1716876-supplement-Supplemental_Table_S5.pdf

View BVdb publication page

Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors.

Frontiers In Oncology

Han, Mei M; Jia, Lina L; Lv, Wencai W; Wang, Lihui L; Cui, Wei W

Publication Date: 2019

Variant appearance in text: EZH2: Q94R

PubMed Link: 30984620

Variant Present in the following documents:

• Main text
• fonc-09-00194.pdf

View BVdb publication page